Paul J. Spiess

10.4k total citations · 5 hit papers
40 papers, 8.4k citations indexed

About

Paul J. Spiess is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Paul J. Spiess has authored 40 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 20 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Paul J. Spiess's work include Immunotherapy and Immune Responses (31 papers), CAR-T cell therapy research (17 papers) and Immune Cell Function and Interaction (16 papers). Paul J. Spiess is often cited by papers focused on Immunotherapy and Immune Responses (31 papers), CAR-T cell therapy research (17 papers) and Immune Cell Function and Interaction (16 papers). Paul J. Spiess collaborates with scholars based in United States, Malaysia and Australia. Paul J. Spiess's co-authors include Steven A. Rosenberg, René Lafrenière, Nicholas P. Restifo, S A Rosenberg, James J. Mulé, Susan Schwarz, S. Schwarz, Paul A. Antony, Christopher A. Klebanoff and Douglas C. Palmer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Paul J. Spiess

40 papers receiving 8.1k citations

Hit Papers

Immunologic and therapeutic evaluation of a synthetic pep... 1985 2026 1998 2012 1998 1986 2005 2003 1985 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul J. Spiess United States 32 6.8k 4.8k 2.1k 1.2k 618 40 8.4k
John R. Yannelli United States 34 5.5k 0.8× 3.6k 0.8× 2.2k 1.0× 793 0.6× 597 1.0× 74 7.3k
Michael J. Mastrangelo United States 46 3.1k 0.4× 3.2k 0.7× 1.9k 0.9× 739 0.6× 592 1.0× 190 6.3k
Kathleen E. Morton United States 17 6.2k 0.9× 6.0k 1.3× 1.9k 0.9× 1.4k 1.1× 300 0.5× 19 8.8k
Willem W. Overwijk United States 49 7.1k 1.0× 4.9k 1.0× 2.7k 1.3× 931 0.8× 390 0.6× 112 9.6k
Paul Aebersold United States 17 2.7k 0.4× 2.8k 0.6× 1.6k 0.7× 1.3k 1.1× 316 0.5× 29 4.9k
Hideaki Tahara Japan 51 5.1k 0.7× 3.5k 0.7× 3.6k 1.7× 1.9k 1.5× 280 0.5× 172 9.0k
Emma Di Carlo Italy 45 4.0k 0.6× 2.9k 0.6× 1.8k 0.8× 616 0.5× 715 1.2× 125 6.1k
Sharon Mavroukakis United States 21 7.0k 1.0× 7.6k 1.6× 2.3k 1.1× 1.9k 1.5× 454 0.7× 36 10.5k
Timothy M. Clay United States 41 3.2k 0.5× 2.2k 0.5× 2.6k 1.2× 796 0.6× 491 0.8× 97 5.9k
Michael I. Nishimura United States 44 4.6k 0.7× 3.2k 0.7× 1.8k 0.9× 885 0.7× 369 0.6× 135 6.5k

Countries citing papers authored by Paul J. Spiess

Since Specialization
Citations

This map shows the geographic impact of Paul J. Spiess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Spiess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Spiess more than expected).

Fields of papers citing papers by Paul J. Spiess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Spiess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Spiess. The network helps show where Paul J. Spiess may publish in the future.

Co-authorship network of co-authors of Paul J. Spiess

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Spiess. A scholar is included among the top collaborators of Paul J. Spiess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Spiess. Paul J. Spiess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Zong Sheng, Julie A. Hong, Kari R. Irvine, et al.. (2006). De novoInduction of a Cancer/Testis Antigen by 5-Aza-2′-Deoxycytidine Augments Adoptive Immunotherapy in a Murine Tumor Model. Cancer Research. 66(2). 1105–1113. 120 indexed citations
2.
Gattinoni, Luca, Steven E. Finkelstein, Christopher A. Klebanoff, et al.. (2005). Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 + T cells. The Journal of Experimental Medicine. 202(7). 907–912. 812 indexed citations breakdown →
3.
Klebanoff, Christopher A., Steven E. Finkelstein, Deborah R. Surman, et al.. (2004). IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8 + T Cells. Proceedings of the National Academy of Sciences. 101(7). 1969–1974. 481 indexed citations
4.
Weinreich, David M., Dina M. Elaraj, Markus Puhlmann, et al.. (2003). Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.. PubMed. 63(18). 5957–61. 42 indexed citations
5.
Pérez‐Díez, Ainhoa, Paul J. Spiess, Nicholas P. Restifo, Polly Matzinger, & Francesco M. Marincola. (2002). Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance. The Journal of Immunology. 168(1). 338–347. 68 indexed citations
6.
Rosenberg, Steven A., Paul J. Spiess, & David E. Kleiner. (2002). Antitumor Effects in Mice of the Intravenous Injection of Attenuated Salmonella Typhimurium. Journal of Immunotherapy. 25(3). 218–225. 66 indexed citations
7.
Rosenberg, Steven A., James Chih‐Hsin Yang, Douglas J. Schwartzentruber, et al.. (1999). Impact of Cytokine Administration on the Generation of Antitumor Reactivity in Patients with Metastatic Melanoma Receiving a Peptide Vaccine. The Journal of Immunology. 163(3). 1690–1695. 141 indexed citations
8.
Rosenberg, Steven A., James Chih‐Hsin Yang, Douglas J. Schwartzentruber, et al.. (1998). Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature Medicine. 4(3). 321–327. 1480 indexed citations breakdown →
9.
Shilyansky, Joel, James Chih‐Hsin Yang, Mary Custer, et al.. (1997). Identification of a T-Cell Receptor from a Therapeutic Murine T-Cell Clone. Journal of Immunotherapy. 20(4). 247–225. 8 indexed citations
10.
Zhai, Yougang, James Chih‐Hsin Yang, Yasuhiko Kawakami, et al.. (1996). Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. The Journal of Immunology. 156(2). 700–710. 133 indexed citations
11.
Minev, Boris, et al.. (1994). Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice.. PubMed. 54(15). 4155–61. 76 indexed citations
12.
Barth, Richard J., James J. Mulé, Paul J. Spiess, & Steven A. Rosenberg. (1991). Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.. The Journal of Experimental Medicine. 173(3). 647–658. 348 indexed citations
13.
Spiess, Paul J., et al.. (1990). Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action.. The Journal of Experimental Medicine. 171(1). 249–263. 97 indexed citations
14.
Rosenberg, S A, S. Schwarz, & Paul J. Spiess. (1988). Combination Immunotherapy for Cancer:Synergistic Antitumor Interactions of Interleukin-2, Alfa Interferon, and Tumor-Infiltrating Lymphocytes. JNCI Journal of the National Cancer Institute. 80(17). 1393–1397. 106 indexed citations
15.
Rosenberg, Steven A., Paul J. Spiess, & Susan Schwarz. (1983). IN VIVO ADMINISTRATION OF INTERLEUKIN-2 ENHANCES SPECIFIC ALLOIMMUNE RESPONSES. Transplantation. 35(6). 631–633. 50 indexed citations
16.
Eberlein, Timothy J., Maury Rosenstein, Paul J. Spiess, & Steven A. Rosenberg. (1982). Generation of Long-Term T-Lymphoid Cell Lines With Specific Cytotoxic Reactivity for a Syngeneic Murine Lymphoma<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 69(1). 109–16. 8 indexed citations
17.
Rosenberg, Steven A., Susan Schwarz, & Paul J. Spiess. (1978). In vitro growth of murine T cells. II. Growth of in vitro sensitized cells cytotoxic for alloantigens.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 121(5). 1951–5. 42 indexed citations
18.
Rosenberg, Steven A., Susan Schwarz, & Paul J. Spiess. (1978). In Vitro Growth of Murine T Cells. The Journal of Immunology. 121(5). 1951–1955. 22 indexed citations
19.
Rosenberg, Steven A., Paul J. Spiess, & Susan Schwarz. (1978). In Vitro Growth of Murine T Cells. The Journal of Immunology. 121(5). 1946–1950. 33 indexed citations
20.
Spiess, Paul J., et al.. (1973). REDUCTION OF PREEXISTING TRANSPLANTATION IMMUNITY BY SPECIFIC PREGNANCY. Transplantation. 15(4). 413–415. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026